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Concerning gaps in the HIV care continuum compromise individual and population health.
We evaluated a combination intervention strategy (CIS) targeting prevalent barriers to timely
linkage and sustained retention in HIV care in Mozambique.
Methods and findings
In this cluster-randomized trial, 10 primary health facilities in the city of Maputo and Inham-
bane Province were randomly assigned to provide the CIS or the standard of care (SOC).
The CIS included point-of-care CD4 testing at the time of diagnosis, accelerated ART initia-
tion, and short message service (SMS) health messages and appointment reminders. A
pre–post intervention 2-sample design was nested within the CIS arm to assess the effec-
tiveness of CIS+, an enhanced version of the CIS that additionally included conditional non-
cash financial incentives for linkage and retention. The primary outcome was a combined
outcome of linkage to care within 1 month and retention at 12 months after diagnosis. From
April 22, 2013, to June 30, 2015, we enrolled 2,004 out of 5,327 adults18 years of age
diagnosed with HIV in the voluntary counseling and testing clinics of participating health
facilities: 744 (37%) in the CIS group, 493 (25%) in the CIS+ group, and 767 (38%) in the
SOC group. Fifty-seven percent of the CIS group achieved the primary outcome versus
35% in the SOC group (relative risk [RR]CIS vs SOC = 1.58, 95% CI 1.05–2.39). Eighty-nine
percent of the CIS group linked to care on the day of diagnosis versus 16% of the SOC
group (RRCIS vs SOC = 9.13, 95% CI 1.65–50.40). There was no significant benefit of adding
financial incentives to the CIS in terms of the combined outcome (55% of the CIS+ group
achieved the primary outcome, RRCIS+ vs CIS = 0.96, 95% CI 0.81–1.16). Key limitations
include the use of existing medical records to assess outcomes, the inability to isolate the
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Conclusions
The CIS showed promise for making much needed gains in the HIV care continuum in our




Why was this study done?
• In sub-Saharan Africa, HIV testing, care, and treatment programs have been widely
scaled up over the past decade, but suboptimal outcomes across the HIV care contin-
uum—particularly with regards to timely linkage to and sustained retention in care—
compromise their effectiveness.
• Patients experience multiple barriers to linkage to and retention in HIV care including
health system barriers, structural barriers, and behavioral barriers, yet prior studies have
largely evaluated individual interventions targeting a single barrier to care.
• Our study was designed specifically to examine the effectiveness of a combination inter-
vention strategy (CIS) composed of several scalable evidence-based interventions target-
ing the multiple and prevalent health system, structural and behavioral barriers that
patients face across the HIV continuum.
What did the researchers do and find?
• We randomly assigned 10 primary health facilities in the city of Maputo and Inhambane
Province in Mozambique to provide the standard of care (SOC) or the CIS, which
included point-of-care CD4 testing at the time of diagnosis, accelerated ART initiation,
and short message service (SMS) health messages and appointment reminders. A pre–
post intervention 2-sample design was nested within the intervention arm to assess the
effectiveness of CIS+, an enhanced version of the CIS that additionally included condi-
tional non-cash financial incentives for linkage and retention.
• We enrolled 2,004 adults diagnosed with HIV in the voluntary counseling and testing
clinics of participating health facilities, and compared the proportion who achieved a
combined outcome of linkage to HIV care within 1 month of diagnosis and retention in
care at 12 months across the 3 study groups.
• We found an increased likelihood of achieving the combined outcome in the CIS group
compared to the SOC group, driven primarily by very large increases in same-day link-
age, but no difference between the CIS+ and CIS groups.
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What do these findings mean?
• The CIS may help improve outcomes across the HIV care continuum in high-burden
settings, particularly in the critical first step of timely linkage to care following
diagnosis.
• Further research is needed to understand whether financial incentives can be optimized
in this setting, given their effectiveness in enhancing other health outcomes.
Introduction
Although the extraordinary scale-up of HIV testing, care, and treatment programs in sub-
Saharan Africa over the past decade has resulted in more than 19 million persons accessing
antiretroviral therapy (ART) [1], the effectiveness of these programs has been significantly hin-
dered by high levels of attrition across the HIV care continuum. Observational studies and sys-
tematic reviews have repeatedly reported disturbing gaps in care as patients move from HIV
testing clinics to HIV care clinics (i.e., linkage to care) and that patient dropout among those
enrolled in HIV care is far too common, both before and after ART initiation (i.e., retention in
care) [2–7]. Indeed, available data suggest that less than 1/3 of individuals who are diagnosed
with HIV are successfully linked to and remain engaged in HIV care 12 months later [4,8].
Barriers to timely linkage to and sustained retention in HIV care have been well docu-
mented, and include health system barriers (e.g., multiple HIV clinic visits for counseling and
clinical and laboratory assessments prior to ART initiation), structural barriers (e.g., transport
costs and distances, work and childcare constraints), and behavioral barriers (e.g., forgetting
appointments, lack of understanding of required care) [9–14]. Prior studies have overwhelm-
ingly evaluated individual interventions targeting a single barrier at a single point in the HIV
care continuum such as mobile phone short message service (SMS) messaging to augment
linkage to care following diagnosis, or point-of-care CD4 testing to enhance retention among
patients enrolled in HIV care [15,16]. However, it is increasingly recognized that multi-com-
ponent approaches composed of several practical, evidence-based interventions that simulta-
neously target the multiple and recurrent barriers that patients face as they navigate across the
HIV care continuum are needed to maximize individual and population health [17,18]. Fur-
ther, implementation science research that evaluates proposed multi-component approaches
in real-world settings is needed to assess not only effectiveness, but also implementation out-
comes including reach, adoption, and sustainability [19]. To this end, we designed a combina-
tion intervention strategy (CIS) composed of several scalable evidence-based interventions
targeting prevalent health system, structural, and behavioral barriers across the HIV care con-
tinuum, and determined its effect on a combined outcome of linkage to and retention in HIV
care among adults newly diagnosed with HIV in Mozambique, while also collecting informa-
tion on its implementation and potential for broader scale-up [20]. Data regarding interven-
tion feasibility and patient acceptability have been published [21], and thus we present here the
effectiveness results. Because the interventions included in the CIS are expected to be imple-
mented at the facility level, as opposed to targeted at specific individuals, should they be scaled
up, we evaluated effectiveness using a cluster design, which best mirrors this implementation
approach.
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Methods
A detailed description of the study protocol has been published [22].
Ethics statement
Ethical approval was provided by Mozambique’s National Committee for Bioethics for Health
and Columbia University’s institutional review board (IRB) (protocol AAAL1354). Informed
written consent was obtained from all participants.
Study design
Between April 22, 2013, and June 30, 2016, we conducted a 2-arm cluster-randomized study
(effectiveness–implementation hybrid design, Type 1) [20] in health facilities in Maputo and
Inhambane Province in Mozambique in order to assess the effectiveness of the CIS. Addition-
ally, a pre–post intervention 2-sample design was nested within the intervention arm to assess
the additional effectiveness of an enhanced version of the CIS, referred to as CIS+. Conse-
quently, the standard of care (SOC) arm enrolled 1 cohort of patients, while the intervention
arm enrolled 2 sequential cohorts of patients (CIS and CIS+). CIS+ participants were enrolled
after CIS enrollment was completed at each facility randomized to the intervention arm.
Study setting
The city of Maputo, the nation’s capital, has an area of 300 km2 and an estimated population of
1,225,868 [23], with an HIV prevalence of 16.9% among those aged 15 to 59 years [24]. The
Maputo City Health Network has a total of 37 health facilities, 32 of which offered comprehen-
sive HIV care and treatment services at the time of study implementation [25]. In contrast,
Inhambane is a rural province, with an estimated 1,475,318 people spread across 68,615 km2
[23]. HIV prevalence among adults aged 15 to 59 years is 14.1% [24]. The ratio of doctors to
population (5.96/100,000) is one of the lowest in the country [26]. Of the 135 health facilities
in the province, 76 offered HIV care and treatment services when our study was initiated [25].
Suboptimal health facility infrastructure, long distances to facilities, and weak referral systems
in the province are all believed to compromise health service uptake [26].
Randomization
Primary health facilities providing HIV testing, care, and treatment services and operated by
the Ministry of Health with technical support from the Center for Collaboration in Health, a
local PEPFAR implementing partner, were the unit of randomization. We focused on primary
health facilities, rather than larger provincial hospitals, to reflect the increasingly decentralized
nature of HIV service delivery in Mozambique. Ten facilities in Maputo (N = 4) and Inham-
bane Province (N = 6) were selected from the 66 primary health facilities receiving technical
support from the Center for Collaboration in Health in those regions. Participating facilities
were purposely chosen because they had the highest volume of adults testing HIV positive and
enrolling in HIV care in the year prior to study start and thus were expected to have sufficient
participants for appropriate power. Facilities were matched into pairs by region (Maputo or
Inhambane), level of urbanicity (urban versus rural), and average number of patients testing
HIV positive in voluntary counseling and testing (VCT) in the year prior to study initiation
(high versus low), resulting in 5 matched pairs. Matched pairs were randomized by one of the
authors (MRL) using a computerized random number generator to either the CIS arm or the
SOC arm using matched-pair randomization. Sequences were concealed until interventions
were assigned. The study was non-blinded.
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Study population
Participants were enrolled in the SOC group beginning on April 22, 2013, and in the CIS
group beginning on April 25, 2013. The last patient was enrolled in the SOC group on Novem-
ber 20, 2014, and the last patient in the CIS group was enrolled on February 11, 2015. Enroll-
ment in the CIS+ group began after each clinic randomized to the intervention arm completed
CIS enrollment, and ran from June 16, 2014, through June 30, 2015. All participants were fol-
lowed for 12 months, with the last patient completing follow-up on June 30, 2016.
Broad inclusion criteria were used to reflect as accurately as possible the population of
adults newly diagnosed with HIV in VCT clinics at the participating health facilities. We
focused on individuals newly diagnosed in VCT clinics, as opposed to those diagnosed in ante-
natal clinics and tuberculosis clinics, because the latter groups of patients typically follow a
modified clinic flow. All adults testing HIV positive in the VCT clinics within the participating
health facilities were informed of the study by HIV testing counselors following diagnosis, and
those who were interested were referred to study staff for further information, eligibility
screening, and consent procedures. Patients were excluded if they were less than 18 years of
age, were pregnant, planned to move from their community of residence in the next 12
months, had enrolled in HIV care or initiated ART in the past 6 months, did not understand
Portuguese or Xitsua, or were incapable of providing informed consent. Study participants
agreed to be referred to HIV care and treatment services at the same facility where they were
diagnosed (referred to as the “diagnosing facility”); to complete a baseline, 1-month, and
12-month interview; to be traced at their homes if they could not be reached by phone for fol-
low-up interviews; to provide contact information for a family member or friend who could
provide information on their vital status if they could not be located for a follow-up interview;
and, if they enrolled in HIV care and treatment services at the diagnosing facility, to have their
clinical data abstracted from the facility’s existing electronic medical records.
Study interventions
Standard of care. Participants at health facilities randomized to receive the SOC were
managed as per prevailing Ministry of Health guidelines [27]. Individuals diagnosed with HIV
received post-test counseling in the VCT clinic and were referred verbally to HIV services, typ-
ically in the diagnosing facility. Patients presenting to the facility receptionist to schedule a
clinical consultation for HIV care were referred to the laboratory for CD4 cell count, chemis-
try, and hematology testing, and provided with an appointment 2–4 weeks later to allow suffi-
cient time for the laboratory results to be received. ART eligibility was determined at that first
clinical consultation based on CD4 cell count 350 cells/mm3 and/or WHO stage 3/4. Those
found to be eligible for ART received at least 1 individual counseling session before initiating
treatment. For ART-eligible patients, the time interval between enrollment in HIV care and
ART initiation was estimated at 1–2 months at the time the study started. Participants initiat-
ing ART were requested to return every 2 weeks for the first month, at 2 months, at 6 months,
and every 6 months thereafter. ART-ineligible patients were instructed to return at 6 months
for repeat clinical evaluation and laboratory testing.
Combination intervention strategy. At facilities randomized to the intervention arm, we
introduced 4 evidence-based interventions that simplified the clinic flow and encouraged link-
age to and retention in care. These interventions targeted several known health system, struc-
tural, and behavioral barriers across the HIV care continuum, and were adapted for the on-
the-ground realities—including practice norms, physical space, and available staffing—at the
health facilities. First, we introduced Pima (Inverness Medical Innovations) CD4 assay
machines in the VCT clinics to enable HIV testing counselors to provide real-time, point-of-
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care CD4 test results immediately following diagnosis, and thus addressed a health system bar-
rier by reducing the number of visits required for CD4 testing. We also hypothesized that
receipt of additional information on one’s health at the time of diagnosis would advance
patient understanding of the need for care, a documented behavioral barrier [10,28]. All
patients regardless of CD4 count were provided with a paper-based referral to on-site HIV ser-
vices that included their CD4 count, and were instructed to present for their first clinical con-
sultation within 1 week. Second, to address additional health system barriers, patients with
Pima CD4 cell count 350 cells/mm3 were provided with accelerated ART initiation, with the
ultimate goal of decreasing the HIV morbidity and mortality that contributes to significant
attrition among ART-eligible patients [4]. These individuals received an individual ART pre-
paratory counseling session in the VCT clinic immediately following CD4 testing, on the day
of diagnosis. Facility receptionists were instructed to expedite appointments for these patients
when they presented to schedule their clinical consultations. Although the patients were
directed to the laboratory to have their blood drawn for baseline laboratory tests required by
national ART guidelines, clinicians were encouraged to initiate ART at the first clinical visit
rather than await the results of the laboratory tests unless the patient presented with comorbid
conditions. Patients who initiated ART received a 2-week supply and followed the visit sched-
ule dictated by national guidelines, similar to the SOC procedures. Once baseline laboratory
results were available, they were reviewed by clinic staff, and if abnormalities were noted, the
participant was contacted to return to the clinic. Third, participants received health messages
and appointment reminders via SMS messaging to address behavioral barriers associated with
deferring care engagement and forgetting appointments. The messages were sent from the
central study office to the participant’s phone or to a friend or relative’s phone per participant
preference, and did not refer to HIV or a specific health facility or reveal any personal informa-
tion. The health messages encouraged participants to care for their health, and were sent weekly
for 1 month following diagnosis and then monthly (e.g., “Hi. Your health is the most important
thing. Please remember to come to the health center for health services.”). Appointment remind-
ers were sent only to participants who linked to care at the diagnosing facility, and were sent 3–7
days before each scheduled clinic visit (e.g., “Hi. Your health is the most important thing. We
expect to see you at your upcoming appointment scheduled for the day ___.”). Participants were
not asked to confirm receipt or reply to the messages. Finally, patients in the CIS+ cohort received
the CIS interventions plus a series of non-cash financial incentives (FIs) in the form of prepaid
cellular air-time cards to offset structural barriers associated with the direct and indirect costs of
coming to the health facility to receive HIV care. Air-time cards rather than cash were selected as
the incentive based on discussion with the Ministry of Health. Each card was valued at approxi-
mately US$5 and was provided conditionally upon the following achievements: linkage to care
within 1 month of diagnosis, retention in care 6 months after diagnosis, and retention in care 12
months after diagnosis, for a total of approximately US$15. Participants who completed each
achievement received the card when presenting for routine services. Participants without cellular
phones could opt to give them to a family member, sell them for cash, or trade them for other
goods. Both the point-of-care CD4 testing and accelerated ART initiation interventions were pro-
vided by health facility staff to all individuals diagnosed with HIV in the VCT clinic regardless of
whether they were enrolled in the study, while the SMS messages and FIs were provided by study
staff and only to study participants.
Data collection and outcomes
Site assessments. Data on the configuration of HIV services at the 10 participating study
sites were collected at the beginning and at the end of the study using a standardized site
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assessment form. The purpose of the site assessments was to identify important similarities
and differences between participating health facilities, as well as to better understand how ser-
vices at the site could impact study implementation.
Baseline interview. Participants completed closed-ended questionnaires administered by
trained research assistants at the time of study enrollment. The questionnaire took about 30
minutes to complete, and gathered information on sociodemographic characteristics, social
and family support, mental health, alcohol use, HIV testing history, HIV knowledge and
beliefs, and anticipated stigma and barriers to care. Anticipated stigma was assessed through 6
items adapted from the 12-item anticipated HIV stigma index developed by Earnshaw and
Chaudoir [29]. Stigma scores were summed, then dichotomized into 2 groups: highest (>75th
percentile) versus lower anticipated stigma. Mental health was assessed via a 7-question evalu-
ation based on the Kessler 10-item scale for psychological distress [30]. Mental health scores
were summed, then dichotomized into 2 groups: highest (<75th percentile) versus lower level
of distress. Perceived availability of social support was assessed with 4 questions adapted from
a 9-item scale by Wortman and colleagues [31]. Social support scores were summed, then
dichotomized into 2 groups: higher (>50th percentile) versus lower social support. Questions
assessing HIV-related knowledge and attitudes were based on those used by one of the authors
in a previous study [32]. HIV knowledge scores were summed, then dichotomized into 2
groups: higher (>50th percentile) versus lower knowledge. Baseline interview data were dou-
ble-entered into a study database, and a computer program identified discrepant double-
entered results for correction against the paper-based forms.
Patient tracing and follow-up interviews. One and 12 months after enrollment, up until
June 30, 2016, trained research assistants contacted participants by phone to ascertain their
vital status and HIV care status, and to administer follow-up questionnaires. If the participant
could not be contacted by phone after 3 attempts, research assistants visited the participant’s
home up to 3 times. Participants who were located completed closed-ended interviews that
gathered updated information on key domains from the baseline questionnaire, as well as self-
reported information on linkage to (1- and 12-month questionnaires) and retention in HIV
care (12-month questionnaire only), reasons for linkage/non-linkage (1- and 12-month ques-
tionnaires) and retention/non-retention (12-month questionnaire only), ART status, hospitali-
zations, and anticipated stigma. In cases where the participant could not be located, research
assistants contacted a friend or family member as specified by the participant at study enroll-
ment. Research assistants did not refer to HIV or the health facility during contact tracing but
rather attempted to determine whether the participant was alive or dead. For those whose vital
status could not be determined through contact tracing, research assistants searched existing
electronic medical records at other primary health facilities supported by the Center for Col-
laboration in Health in the same district to assess whether patients had enrolled in HIV care at
another facility, and reviewed death registers at the municipal and provincial levels to ascertain
their vital status. Similar data entry and reconciliation procedures to those used for the baseline
interview data were used for the tracing and follow-up data.
Abstraction of clinical data for patients linking to HIV care at the diagnosing facility.
As part of routine clinical practice for HIV patients, clinicians documented patient informa-
tion at every clinic visit on national HIV care forms, and trained data clerks entered those data
into an Access-based electronic medical record. In its role as a PEPFAR implementing partner
supporting the study sites, the Center for Collaboration in Health assessed the completeness
and accuracy of these electronic data every 4 months and initiated targeted interventions to
enhance data quality if there was greater than 15% disagreement on key data elements between
the electronic and paper-based systems. During the study period, research assistants reviewed
the electronic medical records to identify study participants who had linked to care at their
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diagnosing facility. For those located, we extracted the complete electronic medical record,
capturing information on visit dates, vital status, transfer status, ART status, laboratory test
results, and opportunistic infections.
Outcomes. The primary outcome was a combined outcome of linkage to HIV care within
1 month of diagnosis plus retention in care 12 months after diagnosis measured at the individ-
ual level. We used a combined outcome to reflect the fact that improvements are needed across
the HIV care continuum in order to maximize individual and population health. Linkage to
care was defined by at least 1 clinical consultation for HIV that included assessment of the
patient’s medical history and a physical exam. Retention in care was defined by a clinic visit in
the 90 days prior to the end of the 12-month study follow-up period, with no documentation
that the patient had transferred to another facility or had died. We assessed the combined out-
come from the perspective of the diagnosing health facility using data from the electronic med-
ical records maintained by the HIV clinics. All study participants were included in these
analyses, including those who did not complete follow-up interviews. Participants whose elec-
tronic medical records were not located were considered not to have achieved the combined
outcome for this analysis. As a secondary approach, we evaluated the combined outcome from
the perspective of the Mozambican health program by supplementing data from the electronic
medical records with patient reports of linkage to and retention in care at HIV clinics at differ-
ent health facilities (obtained during follow-up interviews) and information obtained from
electronic medical records at other health facilities. In these analyses, participants whose self-
reported linkage and retention status suggested they were linked to and/or retained at a health
facility other than their diagnosing clinic were considered to have achieved the respective link-
age/retention outcomes. Participants who either did not complete follow-up interviews or did
not self-report linkage to or retention at another clinic maintained their initial outcome desig-
nation. All study participants were included in these analyses.
Secondary outcomes included linkage to care at several predefined time points, ART eligi-
bility assessment (defined as receipt of WHO staging and/or CD4 cell count), ART initiation,
disease progression (defined as a new WHO stage 3/4 condition or hospitalization noted in the
electronic medical records or self-reported during follow-up interviews), retention in care 6
and 12 months after diagnosis regardless of the timing of linkage, and death.
Statistical analysis
The trial was designed and powered to measure outcomes at the individual level, with out-
comes assessed within each cluster (5 clusters per arm). In our initial power calculations, we
anticipated that an average of 200 patients per clinic (in the CIS and SOC arms) would be eligi-
ble for enrollment based on historical data on the annual number of adults testing positive in
the VCT clinics at the participating health facilities. With 5 facilities per study arm, an average
of 200 patients per facility, an intraclass correlation coefficient (ICC) of 0.05, and an alpha of
0.05 and assuming that 35% of participants in the SOC arm would achieve the primary out-
come, we estimated that the study would have 80% power to detect as statistically significant
55% of participants in the CIS group achieving the primary outcome, and greater than 80%
power to detect as statistically significant 75% of participants in the CIS+ group achieving the
primary outcome. Because enrollment proceeded slower than originally planned, at study mid-
point we assessed the implications for power if each health facility enrolled an average of 150
participants rather than 200. Our calculations revealed minimal change in power with this
reduction in the number of participants per health facility. Calculations were performed using
PASS 8.0 software for 2 independent proportions in a cluster randomization study design and
a 2-sided Farrington and Manning Likelihood Score Test [33]. Our power estimations and
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statistical analyses did not take into account the pair matching prior to randomization but
rather followed recommendations from Diehr et al. [34] to break matches in statistical analyses
of clustered studies when the number of pairs is between 3 and 9.
An intent-to-treat analysis determined the relative risk (RR) of achieving study outcomes
between the CIS and SOC groups, and between the CIS+ and CIS groups. For analyses of
the primary outcome, we used random-intercept multilevel log-Poisson models to account
for clustering within health facilities with an empirical variance adjustment for small num-
bers of sampling units described by Morel et al. [35]. We also assessed whether the primary
outcome differed after adjustment for patient-level factors by constructing propensity
scores that estimated the probability of inclusion in the CIS, CIS+, and SOC groups by age,
sex, region, education, income, employment status, marital status, religion, prior year his-
tory of being away from home for more than 1 month, travel time to clinic, tuberculosis sta-
tus, past hospitalizations, diagnosis history, and whether another family member was
known to be living with HIV. The propensity score was included as a covariate in the multi-
variable log-Poisson models (adjusted analyses). In post hoc analyses, we further estimated
the likelihood of key subgroups achieving the primary outcome using interaction contrast
ratios. The subgroups assessed included subgroups based on baseline age, sex, region of
health facility, employment status, marital status, whether the participant was away from
home for more than 1 month in the year prior to study enrollment, travel time to clinic,
whether a household member was known to be HIV positive, and dichotomous variables
based on scales for self-reported anticipated stigma, HIV knowledge, mental health, and
perceived social support as described earlier. For analyses of secondary outcomes, log-Pois-
son models were used for dichotomous outcomes, and t tests and 2-way median tests as




As noted above, 10 primary health facilities participated in the study, 4 in Maputo and 6 in
Inhambane. At study start, the 5 health facilities randomized to the intervention arm reported
that they had experienced disruptions of 3 or more days in VCT services in the prior 12
months, while only 1 facility randomized to the SOC arm reported experiencing a similar dis-
ruption. By study end, no facilities—whether in the intervention or SOC arm—had experi-
enced such disruptions. Throughout the study, only intervention sites conducted point-of-
care CD4 testing using Pima machines in the VCT clinic. Two SOC sites reported that they
had Pima machines available in their laboratories but only used them to monitor CD4 counts
after patients had enrolled in HIV care. None of the SOC sites used SMS messaging for health
messages or appointment reminders on a routine basis for all patients, but 2 sites sent SMS
appointment reminders for patients participating in community ART groups [36]. Though the
2013 national HIV treatment guidelines stipulate that 1 ART preparatory counseling session is
required for ART-eligible patients, all the facilities participating in the study typically con-
ducted 2 to 3 sessions prior to ART initiation, with a slight reduction in the number of sessions
observed between study start and end.
Enrollment and participant characteristics
Fig 1 shows the enrollment, exclusion, and flow of the patients by study group. During the
study period, 5,327 adults18 years of age were diagnosed with HIV in the VCT clinics at the
10 study facilities. A total of 265 of those individuals were not referred to the study staff for
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further information on the study because they informed the HIV testing counselor that they
were not interested in the study, were already receiving HIV services, or were not willing to be
referred to the diagnosing health facility. Among the 5,062 who were referred to the study staff
for further information, 3,058 did not meet study eligibility criteria. The main reasons for
exclusion were inability to provide informed consent due to distress following diagnosis
(19%), inability to understand Portuguese or Xitsua (12%), and refusal to be referred to the
diagnosing health facility for HIV services (10%).
A total of 2,004 adults18 years of age enrolled in the study at the 10 health facilities: 744
(37%) in the CIS group, 493 (25%) in the CIS+ group, and 767 (38%) in the SOC group. The
majority of participants were female (64%), and the median age of participants was 34 years of
age, with no meaningful differences observed by study group (Table 1). More than half of the
participants (53%) were living with a partner at the time of diagnosis, and 65% of participants
had a primary or lower level of education. Most participants (74%) were employed, and 43%
had a monthly income of less than 1,500 meticais (approximately US$50). One-quarter (27%)
reported that another household member was living with HIV. While no serious adverse
events were reported during the study period, there was 1 unanticipated event of a female par-
ticipant reporting intimate partner violence. The Mozambican National Committee for
Fig 1. Flow chart for study participation. CIS, combination intervention strategy; SOC, standard of care; VCT, voluntary counseling and testing.
https://doi.org/10.1371/journal.pmed.1002433.g001
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Bioethics for Health and the Columbia University IRB were informed of this event, and the
participant asked to remain in the study but to conduct all study interviews at the facility (i.e.,
no follow-up phone calls).
Intervention effect on linkage to and retention in HIV care at the
diagnosing facility
As shown in Table 2, the CIS was associated with statistically significant improvements in the
combined outcome of linkage to care within 1 month of diagnosis and retention in care 12











Maputo 1,077 (54%) 396 (53%) 275 (56%) 406 (53%) 0.58
Inhambane 927 (46%) 348 (47%) 218 (44%) 361 (47%)
Sex 0.50
Female 1,292 (64%) 490 (66%) 319 (65%) 483 (63%)
Male 712 (36%) 254 (34%) 174 (35%) 284 (37%)
Age (years) 34.2 (9.6) 34.9 (9.8) 33.8 (9.9) 33.8 (9.3) 0.045
18–24 265 (13%) 90 (12%) 70 (14%) 105 (14%) 0.12
25–39 1,233 (62%) 440 (59%) 301 (61%) 492 (64%)
40–49 348 (17%) 148 (2%) 87 (18%) 113 (15%)
50+ 158 (8%) 66 (9%) 35 (7%) 57 (7%)
Marital status <0.001
Married/partner and living together 1,068 (53%) 376 (51%) 255 (52%) 437 (57%)
Married/partner, but not living together 222 (11%) 101 (14%) 86 (17%) 35 (5%)
Single 713 (36%) 266 (36%) 152 (31%) 295 (38%)
Missing/refused 1 (0%) 1 (0%) 0 (0%) 0 (0%)
Education 0.003
None 164 (8%) 59 (8%) 33 (7%) 72 (9%)
Primary 1,149 (57%) 442 (59%) 256 (52%) 451 (59%)
Secondary 471 (24%) 164 (22%) 130 (26%) 177 (23%)
Above secondary 219 (11%) 78 (1%) 74 (15%) 67 (9%)
Missing/refused 1 (0%) 1 (0%) 0 (0%) 0 (9%)
Employment 0.46
Employed 1,473 (74%) 537 (72%) 361 (73%) 575 (75%)
Unemployed 531 (26%) 207 (28%) 132 (27%) 192 (25%)
Monthly income <0.001
1,500 meticais 871 (43%) 342 (46%) 165 (33%) 364 (47%)
>1,500 meticais 936 (47%) 343 (46%) 271 (55%) 322 (42%)
Missing/refused 197 (1%) 59 (8%) 57 (12%) 81 (11%)
Another household member has HIV 0.28
Yes 550 (27%) 187 (25%) 144 (29%) 219 (29%)
No 913 (46%) 361 (49%) 219 (44%) 333 (43%)
Don’t know 539 (27%) 196 (26%) 130 (26%) 213 (28%)
Missing/refused 2 (0%) 0 (0%) 0 (0%) 2 (0%)
Data given as N (percent).
CIS, combination intervention strategy; SOC, standard of care.
https://doi.org/10.1371/journal.pmed.1002433.t001
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months following diagnosis when compared to the SOC. Analyses using data from electronic
medical records to examine linkage to and retention at the diagnosing health facility showed
that 57% of participants in the CIS group achieved the primary outcome versus 35% of those
in the SOC group (RRCIS vs SOC = 1.58, 95% CI 1.05–2.39). Post hoc calculation of the ICC for
the primary outcome according to the methods of Snijders and Bosker for binary outcome
data [37] estimated an ICC of 0.066, similar to but slightly higher than the assumed ICC of
0.05 used in power and sample size estimation. These results were robust to adjustment for
patient-level differences (adjusted RR [aRR]CIS vs SOC = 1.55, 95% CI 1.07–2.25). As shown in
Fig 2, the greatest intervention effects were observed among young adults age 18–24 years
(RRCIS vs SOC = 2.39, 95% CI 1.51–3.80, p-value for interaction between age and treatment
arm = 0.07), those in Maputo (RRCIS vs SOC = 2.31, 95% CI 1.90–2.79, p-value for interaction
between region and treatment arm < 0.0001), those who did not report that another house-
hold member was living with HIV (RRCIS vs SOC = 1.81: 95% CI 1.52–2.16, p-value for interac-
tion between household member with HIV and treatment arm = 0.11), and those reporting
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1RR accounts for clustering within sites using random-intercept log-Poisson regression with empirical standard error estimates.
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high levels of anticipated stigma at enrollment (RRCIS vs SOC = 1.95, 95% CI 1.53–2.49, p-value
for interaction between stigma and treatment arm = 0.10).
Eighty-nine percent of participants in the CIS group linked to the diagnosing facility on the
same day as diagnosis compared to 16% (RRCIS vs SOC = 9.13, 95% CI 1.65–50.40) in the SOC
group, 91% within 1 week compared to 46% (RRCIS vs SOC = 2.43, 95% CI 0.70–8.41), and 94%
within 1 month compared to 63% (RRCIS vs SOC = 1.48, 95% CI 0.93–2.35). By 12 months, nearly
all CIS participants (96%) had linked to care compared to 77% (RRCIS vs SOC = 1.23, 95% CI 1.03–
1.48) of SOC participants. Among those linking to care, the median (interquartile range [IQR])
time from diagnosis to linkage was 0 days (0–0) in the CIS group and 3 days (1–26) in the SOC
group (median test p< 0.001 for CIS versus SOC). The effect of the intervention on retention in
care, regardless of the timing of linkage, was more modest but statistically significant (6-month
retention: 62% CIS versus 53% SOC, RRCIS vs SOC = 1.18, 95% CI 1.00–1.39; 12-month retention:
58% CIS versus 44% SOC, RRCIS vs SOC = 1.32, 95% CI 1.12–1.54).
In analyses restricted to the participants initiating ART, the median (IQR) time from
diagnosis to ART initiation in the CIS and SOC groups was 32 (12–135), and 63 (33–230)
days, respectively, while the median (IQR) time from enrollment in HIV care to ART initia-
tion was 32 (11–127), and 50 (15–205) days, respectively. Median time from ART eligibility
to ART initiation for the CIS, CIS+, and SOC groups was 21 (9–40), and 25 (11–56) days,
respectively.
There was no additional benefit of adding FIs to the CIS, with 55% (RRCIS+ vs CIS = 0.96,
95% CI 0.81–1.16; aRRCIS+ vs CIS = 0.94, 95% CI 0.76–1.18) of those in the CIS+ group achiev-
ing the primary outcome; 95% (RRCIS+ vs CIS = 1.00, 95% CI 0.83–1.13) linking to HIV care
within 1 month of diagnosis, regardless of retention at 12 months; and 55% (RRCIS+ vs CIS =
0.95, 95% CI 0.79–1.13) being retained in care 12 months after diagnosis, regardless of the tim-
ing of linkage to care.
Intervention effect on linkage to and retention in care at any health facility
Analyses supplementing data from electronic medical records from participating facilities with
data from patient interviews and other health facilities in the study regions to examine linkage to
and retention at any health facility showed similar effects of the intervention package. A total of
74% (RRCIS vs SOC = 1.47, 95% CI 1.08–2.01) of participants in the CIS group and 47% in the SOC
group were found to have linked to HIV care at any health facility within 1 month of diagnosis
and were retained in HIV care 12 months after diagnosis (Table 2). Adjustment for patient-level
differences did not result in any change in this finding (aRRCIS vs SOC = 1.46, 95% CI 1.05–2.04).
Inclusion of FIs in the CIS also showed no additional benefit for linkage to and retention at any
health facility, with 73% (RRCIS+ vs CIS = 0.98, 95% CI 0.85–1.15; aRRCIS+ vs CIS = 0.96, 95% CI
0.83–1.11) of those in the CIS+ group known to have linked to and been retained in HIV care at
any health facility compared to the CIS group.
Intervention effect on ART eligibility and initiation, disease progression,
and death
Data from electronic medical records at study sites indicated that compared to patients in the
SOC group, patients in the CIS group were more likely to ever have their ART eligibility
assessed (100% versus 76.9%, RRCIS vs SOC = 1.29, 95% CI 1.08–1.54), be identified as ART eli-
gible (75% versus 60%, RRCIS vs SOC = 1.24, 95% CI 1.07–1.43), and initiate ART (65% versus
54%, RRCIS vs SOC = 1.20, 95% CI 1.00–1.43) (Table 3). Very few participants were diagnosed
with a new WHO stage 3/4 event at the diagnosing facility or self-reported a hospitalization in
the 12 months after HIV diagnosis. Those in the CIS group had a non-significantly but
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modestly decreased risk compared to those in the SOC group (1% versus 3%, RRCIS vs SOC =
0.38, 95% CI 0.07–2.03), while similar results were observed between the CIS and CIS+ groups
(1% versus 1%, RRCIS+ vs CIS = 0.65, 95% CI 0.12–3.64). Neither the CIS nor the CIS+ interven-
tions had a significant effect on mortality within 12 months of diagnosis, with 6%, 5%, and 7%
of participants in the CIS, CIS+, and SOC groups, respectively, known to have died during
study follow-up (RRCIS vs SOC = 0.87, 95% CI 0.40–1.91; RRCIS+ vs CIS = 0.88, 95% CI 0.45–
1.74). The CIS also did not have a significant impact on mortality before (3%, RRCIS vs SOC =
0.78, 95% CI 0.46–1.32) or after ART initiation (3%, RRCIS vs SOC = 0.96, 95% CI 0.26–3.48);
Fig 2. Relative risk of the CIS compared to the SOC on the primary outcome at the diagnosing health facility by patient characteristics. a Fifteen
patients with missing information were excluded from this estimate. A description of the variables examined and categories used are provided in the
Methods section.
https://doi.org/10.1371/journal.pmed.1002433.g002
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participants in the CIS+ group were less likely to die, though non-significantly so, before initi-
ating ART compared to those in the CIS group (1% versus 3%, RRCIS+ vs CIS = 0.34, 95% CI
0.09–1.29).
Discussion
We conducted a cluster-randomized study in Mozambique to examine the effectiveness of a
multi-component approach to increase linkage to and retention in HIV care—2 critical ele-
ments of the HIV care continuum—among adults newly diagnosed with HIV. The operational
model of the CIS that we evaluated addresses known structural, biomedical, and behavioral
barriers across the HIV care continuum and was composed of evidence-based, practical, and
scalable interventions, including CD4 testing in VCT clinics with immediate turnaround of
results, accelerated ART initiation for eligible individuals, and SMS health messages and
appointment reminders. An enhanced version of the CIS additionally included FIs. In the
spirit of implementation science, 2 of the interventions were implemented by existing health
facility staff, rather than study staff, providing information on the real-world successes and
challenges associated with the CIS that can be extrapolated to a range of settings with similar
implementation contexts.
Our study showed that participants receiving the CIS were 1.58 times more likely to link to
HIV care at their diagnosing facility within 1 month of diagnosis and be retained in care at
that same facility 12 months following diagnosis, representing not only a statistically signifi-
cant but also a programmatically meaningful improvement. Particularly impressive gains were
observed in timely linkage to care at the diagnosing facility: 89% of CIS participants linked to
care on the day of diagnosis, representing a greater than 5-fold improvement compared to the
SOC, and nearly universal linkage (96%) was achieved within 1 month of diagnosis. Notably,
the intervention effect was greatest in subpopulations documented to have particularly poor
outcomes across the HIV care continuum, including young adults [38,39] and those with high
stigma perceptions [40–42]. The intervention also had beneficial effects on other important
milestones in the HIV care continuum in the 12 months following diagnosis, including the
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likelihood of patients having their ART eligibility assessed and initiating ART. While the inter-
vention significantly increased retention in HIV care at both 6 and 12 months following diag-
nosis, retention in the CIS group remained concerningly low and far short of what is needed
to end the HIV epidemic in Mozambique and other high-burden countries.
We found no additional gain in effectiveness from adding FIs to the CIS. Prior studies
examining the effect of FIs in enhancing outcomes across the HIV care continuum among
people living with HIV have shown inconsistent results. Studies from India, Uganda, and
Democratic Republic of the Congo reported reductions in time to ART initiation and imp-
rovements in retention with the provision of incentives, while in the United States, random-
ized trials did not show any effect of FIs on linkage to care or viral load suppression [43–47].
While 89% of participants in the current study reported that the type of FI provided and the
amount of the FIs (i.e., mobile phone air-time vouchers worth approximately US$5 at 3 points
in time) were adequate, it is possible that the FIs were not sufficiently optimized to affect
behaviors. Indeed, as reported elsewhere, patient reactions to the FIs were surprisingly tepid,
with only 21% reporting it to be the “most useful” intervention for retention in care 12 months
following diagnosis [21]. Additionally, fidelity to the FI component of the intervention package
was imperfect, with, for example, 86% of participants eligible to receive the first incentive actu-
ally receiving it, which may have further limited the effect of this intervention [21]. However,
given the benefits of FIs in other health sectors [48–50], further research is needed to under-
stand whether and how they may be optimized to enhance outcomes across the HIV care
continuum.
This study has several important strengths. It is among the first studies to evaluate the
impact of a multi-component approach on 2 important HIV care and treatment indicators:
timely linkage to care following an HIV diagnosis and sustained retention in care. Improving
performance for these 2 elements of the HIV care continuum is critical for realizing the indi-
vidual and population benefits of HIV programming in sub-Saharan Africa. Further, while
studies have examined the effectiveness of multi-component intervention packages that
include FIs on HIV care outcomes [51,52], this study is the first to our knowledge to use a
design that permits estimation of the additional benefit of including FIs as part of such a
package.
Our study also had limitations. First, in alignment with recent recommendations for imple-
mentation science studies [19], we used existing electronic medical records in the HIV clinics
at the study sites to ascertain outcomes at the diagnosing facility, but such records may have
limited data quality. However, data quality assessments were conducted regularly during the
study period and ensured at least 85% concurrence between paper-based and electronic medi-
cal records on key data elements. Second, aside from the FI, we cannot unpack the effect of
individual intervention components. Third, the relevance of point-of-care CD4 count testing
may change as countries adopt “treatment for all” strategies, although our results suggest that
providing people living with HIV with additional information on their health status immedi-
ately following diagnosis may be important in facilitating same-day linkage to care and likely
same-day ART initiation. Fourth, the CIS+ cohort was enrolled once the target sample size
had been reached in the CIS cohort, thus introducing the potential for secular trends to have
biased the comparison of the CIS and CIS+ packages. However, because we found no differ-
ence in the primary outcome between the CIS+ and CIS groups, secular trends would have
had to have operated in the direction of reducing overall linkage and retention for this bias to
result in the failure to observe an additional benefit of FIs for linkage and retention. While this
is plausible, we do not have any evidence that a substantial reduction in overall linkage and
retention occurred over the relatively limited time frame of the study. Finally, while the study
was implemented in 2 contrasting settings within Mozambique, study facilities were located
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primarily in urban and semi-urban areas within the city of Maputo and Inhambane Province,
which may limit generalizability. Indeed, settings with lower education and cell phone cover-
age than those included in our study may experience greater challenges implementing the
SMS health messages and appointment reminders. Similarly, while we set broad inclusion cri-
teria, we did exclude people who did not understand Portuguese or Xitsua, were planning on
leaving the community, or were not willing to receive services at the diagnosing facility, all fac-
tors that may have reduced generalizability. Finally, due to slower-than-expected enrollment,
we enrolled fewer participants in the CIS+ group than intended, which decreased our power to
detect statistically significant differences in study outcomes between the CIS+ and CIS groups.
However, as the proportion achieving the combined outcome in the 2 groups was extremely
similar (CIS 57% versus CIS+ 55%), it is unlikely that the inability to detect significant differ-
ences was primarily due to lack of power.
Conclusion
Multi-component intervention strategies have been proposed to address troubling gaps in the
HIV care continuum [17,18]. To our knowledge, this is amongst the first studies to rigorously
evaluate such an approach. The CIS we examined, comprising 3 evidence-based, practical, and
scalable interventions, holds great promise as an approach to make much needed gains in the
HIV care continuum in sub-Saharan Africa, particularly in the critical first step of timely link-
age to care following diagnosis.
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